Introductory Paragraph:
Introduction

40
Mutation density, at different scales, has been shown to correlate with different 41 genomic features, such as regional GC-content or recombination rate 1-5 . In cancer,
Results
69
We compared the mutation density distribution in human (1kGP 28 , sgdp_50 29 ), non-70 human Great Apes (NHGA: chimpanzee 30,31 , gorilla 30,32 ), and human cancer 33 datasets.
71
We focused on high-quality orthologous regions shared between human, chimpanzee 72 and gorilla genomes, measuring the number of variants per 1Mbp independently of the 73 frequency of each variant (see Methods).
75
In agreement with previous reports 1,3,4,6 , we observe a variable distribution of the 76 mutation density across the genome in all datasets (Figure 1a) . Mutation densities 77 correlate weakly between the human germline and tumors 1,6 ( Table 1) . Strikingly, the 78 NHGA-tumor correlations are much stronger than the human-tumor correlation and are 79 similar to the human-NHGA germline correlations ( 
81
We compared the distribution of mutation density between pairs of datasets 82 (Supplementary Figure 1) . Interestingly, we observed that mutation density in tumors 83 is higher in windows where NHGAs have higher mutation density than humans 84 (Figures 1b,c) . To control for differences in the shapes of distributions, we ranked 85 each set of windows according to their mutation density (Figures 1d,e ). These ranked 86 distributions show a clear pattern: tumor mutation densities are higher in windows with 87 higher ranks in NHGAs than in human (two-sided Mann-Whitney U test p-value human-88 chimpanzee= 3.7e-216; human-gorilla = 2.8e-161). This behavior is exclusive to 89 human-NHGA comparisons, as it cannot be observed when comparing chimpanzee to 90 gorilla (Supplementary Figure 1) , and can be replicated under different conditions and High-diversity NHGA subspecies have stronger correlations with both human and 95 tumor than the low-diversity subspecies ( Supplementary Table 3 ). Furthermore, the 96 diagonal pattern is only characteristic of comparisons between the germlines of 97 humans and high-diversity NHGA subspecies. A comparison of high and low-diversity 98 chimpanzee and gorilla subspecies showed a clear horizontal split (Supplementary 99 Figure 2 ). Mutation density in tumors co-localizes with the most diverse NHGA 100 subspecies, regardless of the mutation density in the least diverse. In other words; 101 while a lack of diversity distorts the distribution of the genome-wide mutation densities, 102 the diagonal pattern is caused by effects intrinsic to the human lineage. We observed a 103 weak intermediate pattern when comparing NHGA to three archaic hominid genomes 104 ( Supplementary Figure 1; Supplementary Note) . This suggests that at least part of 105 the differentiation process in the distribution of mutation densities was already 106 established before the human-Neanderthal split.
108
Interestingly, correlations between a variety of genomic features and tumor mutation 109 density are consistently more similar to the correlations with NHGAs than with humans 110 (Figure 2a ). Mutation densities in NHGAs have, like in humans, strong correlations 111 with sequence conservation and recombination rate (Supplementary Figure 3) .
112
However, and strikingly, NHGAs show strong positive correlations with epigenomic 113 features associated with closed chromatin, just as tumors do (Figure 2a, 114 Supplementary Table 7 ). We also observe consistent associations with human 115 chromatin states 34 (Figures 2b,c) . GC-content, H3K36me1, and CpG-content show a 116 clear positive correlation with human but negative with NHGAs and tumors, suggesting 117 that they might be contributing to the diagonal pattern (Figure 2d,e and 3a,b ).
118
Interestingly, H3K36me1 has been shown to be specifically recruited in the gene Intrigued by the connection of several CpG-related features with the diagonal pattern 122 that implies stronger correlation between mutation densities in tumors and NHGA than 123 with the human germline (Figure 3a,b) , we analyzed separately CpG>T transitions and 124 mutations at non-CpG sites. (Figure 3c-f ). CpG>T transitions present very strong 125 correlations between all germline datasets and very poor correlations with tumor 126 (Figure 3c,d) . The relationship between CpG-content and mutation density at non-
127
CpG sites is different in humans compared to NHGAs and tumors. Moreover, their 128 correlations are similar to those using all sites (Figure 3e,f 
153
A subset of trinucleotides is significantly enriched in one of the species (Chi-Squared 154 test p-value <10e-5). We detected no association between these trinucleotides and Supplementary Table 12 ). Signatures SBS5 and SBS40 showed a significant 168 association (signature-difference test p-value <10e-4, see Methods) of the pattern with 169 the tumor's signature mutation load (Figure 4b) . Both SBS5 and SBS40 are flat 170 signatures whose mutation load is associated with the age of the sample and with pre-171 neoplastic mutations in tumors 17, 38 This suggests that the strong correlation between 172 NHGA and tumor mutation densities is driven by conserved mechanisms in healthy 
197
We observed that human and other primates showed a very similar global triplet 198 mutation spectrum. We detected an enrichment of certain trinucleotide mutations in As previously described for human 20,37 , we observed that mutation rates of three non-207 human Primates are explained by mutation signatures SBS1 (mostly CpG>T 208 mutations) and SBS5 (associated with "normal" accumulation of mutation in healthy 209 somatic and germline cells 16, 39 ). Moreover, the lower human-tumor than NHGA-tumor 210 correlation is driven by the accumulation of mutations associated with signatures SBS5 211 and SBS40 (similar to SBS5 and recently discovered 17 ). These results suggest that the 212 poor human-tumor correlation is caused by the fact that human (but not NHGAs) 213 germline (and de novo mutations) do not currently reflect the expected mutation Figure 1, Supplementary Table 2 ).
273
These filters were applied to all datasets used, including both our callings and external 274 datasets used as released. All SNV counts, trinucleotide counts, and genomic features 
300
To measure the significance of the diagonal split pattern observed when comparing the 301 human and NHGA datasets, we divided all windows into two groups depending on if 302 the ranked mutation density is higher in human than NHGAs or vice-versa. We 303 calculated the two-sided Mann-Whitney U test on the variable of interest (usually, the 304 tumor mutation density) on both groups using the R function wilcox.test.
306
Genomic Features:
307
The genomic features used were filtered using the same mappability, callability and 308 copy-number filters used for the mutation density data. The features used were either 309 the overlap of the feature's genomic coordinates with the fraction of the 1Mbp window 310 passing our filtering (e.g. GC-content, CpG-content), or the average value or intensity 311 of the feature in the passing fraction of the window (e.g. histone marks), depending on 312 the original data ( Supplementary Table 7 ).
314
Trinucleotides:
315
We classified each SNV into the 96 possible combinations of trinucleotides (12 316 different mutation types, by 16 combinations of the adjacent nucleotides, divided by 317 two when folding them). We determined the adjacent reference sequence of each SNV 318 using the getfasta option of bedtools 53 . We filtered out any variant where the liftOver 319 tool 43 could not map them to the chimpanzee panTro5 or the gorilla gorGor5 reference 320 genomes, or the trinucleotide sequence differed in one of the three reference 321 genomes. This filter was applied to all windows and we used for our analysis only 322 windows where ≥50% of it passed both the original high-quality orthologous regions 323 and this 3-reference filter, leaving 4,920 windows to use. We applied additional filters 324 14 requiring the trinucleotide to be species-exclusive and to not overlap variants in other 325 species (Supplementary Note) . This resulted in a high-confidence set of species-326 exclusive trinucleotides where the ancestral and derived alleles could be reliably 327 inferred. This filtering affected more CpG>T than non-CpG sites, due to the recurrent 328 nature of CpG>T transitions ( Supplementary Table 10 ).
330
Mutation spectra:
331
We calculated each species' mutation spectra as the fraction of all trinucleotides in a 332 dataset belonging to one of the 96 trinucleotides. We calculated correlations between 333 datasets using Pearson's correlation (cor.test function in R). We measured the 334 correlation of the mutation spectrum of each species and the combined effect of cancer 335 mutation signatures SBS1 and SBS5 17,38 by the formula: 0.1*SBS1+0.9*SBS5, as
336
CpG>T transitions are the main components of signature SBS1 and they represent 337 ~10% of the trinucleotides in both the human and NHGA datasets.
339
Whole-genome enrichment of trinucleotides:
340
We calculated the enrichment and its significance in each germline dataset pair 341 (human-chimpanzee, human-gorilla, chimpanzee-gorilla) using the method described 342 in Harris, 2017 25 . We calculated the enrichment of trinucleotide T between species A 343 and B by dividing fraction of T in species A / fraction of T in species B. We calculated a 
361
We developed a method to determine which trinucleotides contribute significantly to the 362 difference between NHGAs-tumors and human-tumors mutation density correlations:
363
For each trinucleotide T and each pair of species (human-chimpanzee, human-gorilla, 364 and, chimpanzee-gorilla) we, subtract the ranked mutation density of T in species A 365 minus the ranking in tumor, and in species B minus tumor. We calculate the two-sided 
382
In order to determine the contribution of each mutation signature to the difference 383 between NHGAs-tumors and human-tumors mutation density correlations, we rerun 384 the trinucleotide-difference test using the 1kGP and chimpanzee datasets, while using 385 the different individual tumor types ( Supplementary Table 12 
546
The numbers next to the legend represent the fold-enrichment between the 95 th and 5 th 
